Research Paper Volume 16, Issue 14 pp 11275—11288

Interference with ANXA8 inhibits the malignant progression of ovarian cancer by suppressing the activation of the Wnt/β-catenin signaling pathway via UCHL5

class="figure-viewer-img"

Figure 7. Interference with ANXA8 inhibited the activation of Wnt/β-catenin signaling pathway via UCHL5. Western blot analysis of Wnt/β-catenin signaling pathway-related proteins. ***P<0.001 vs. control; ##P<0.01, ###P<0.001 vs. shRNA-ANXA8+Ov-NC.